[CLINICAL EVALUATION OF A NEW SULFONAMIDE (GANTANOL) IN THE TREATMENT OF URINARY INFECTIONS].
D003353:Corynebacterium diphtheriae; D004927:Escherichia coli Infections; D011512:Proteus Infections; D011552:Pseudomonas Infections; D013203:Staphylococcal Infections; D013290:Streptococcal Infections; D013420:Sulfamethoxazole; D013449:Sulfonamides; D014552:Urinary Tract Infections
D013449:Sulfonamides; D013420:Sulfamethoxazole
CORYNEBACTERIUM DIPHTHERIAE; ESCHERICHIA COLI INFECTIONS; PROTEUS INFECTIONS; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; SULFAMETHOXAZOLE; SULFONAMIDES; URINARY TRACT INFECTIONS
EVALUATION CLINIQUE D'UN NOUVEAU SULFAMID'E (GANTANOL) DANS LE TRAITEMENT DES INFECTIONS URINAIRES.